Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02492737
Title Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Agios Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Aurora Colorado 80045 United States Details
Chicago Illinois 60611 United States Details
Boston Massachusetts 02215 United States Details
New York New York 10065 United States Details
Houston Texas 77030 United States Details
Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field